Frontiers in Pharmacology | Renal Pharmacology

Systematic Review

Published on 11 Feb 2022

Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis

in Renal Pharmacology

Chia-Hsien Chen
Wei-Cheng Lo
Ping‐Jen Hu
Hsiu-Chen Chan
Wan-Chen Shen
Mai-Szu Wu
Mei-Yi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.822178

21,650 views
21 citations

Original Research

Published on 10 Feb 2022

Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway

in Renal Pharmacology

Linzi Long
Xiuli Zhang
Ying Wen
Jiapeng Li
Lihui Wei
Ying Cheng
Huixin Liu
Jianfeng Chu
Yi Fang
Qiurong Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2021.770863

3,372 views
18 citations

Original Research

Published on 10 Feb 2022

Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy

in Renal Pharmacology

Yuzi Cai
Zhendong Feng
Qi Jia
Jing Guo
Pingna Zhang
Qihan Zhao
Yao Xian Wang
Yu Ning Liu
Wei Jing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.801094

6,585 views
27 citations

Review

Published on 10 Feb 2022

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease

in Renal Pharmacology

Yinghui Wang
Lu Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.800950

10,221 views
63 citations

Original Research

Published on 07 Feb 2022

Combining Neprilysin Inhibitor With AT2R Agonist Is Superior to Combination With AT1R Blocker in Providing Reno-Protection in Obese Rats

in Renal Pharmacology

Elizabeth Alana Gray
Sanket N. Patel
Peter A. Doris
Tahir Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2021.778953

3,094 views
1 citation

Systematic Review

Published on 07 Feb 2022

Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

in Renal Pharmacology

Ming-Zhu Zhang
Wujisiguleng Bao
Qi-Yan Zheng
Ya-Hui Wang
Lu-Ying Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2022.819327

14,258 views
31 citations

Original Research

Published on 04 Feb 2022

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19

in Renal Pharmacology

Kai Kang
Yunpeng Luo
Yang Gao
Jiannan Zhang
Changsong Wang
Dongsheng Fei
Wei Yang
Xianglin Meng
Ming Ye
Yan Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.817793

8,332 views
21 citations

Original Research

Published on 31 Jan 2022

SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease

in Renal Pharmacology

Qianqian Yang
Wenjia Xie
Xiao Wang
Jing Luo
Yang Zhou
Hongdi Cao
Qi Sun
Lei Jiang
Junwei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.707006

4,060 views
7 citations

Original Research

Published on 28 Jan 2022

Ketamine Induced Bladder Fibrosis Through MTDH/P38 MAPK/EMT Pathway

in Renal Pharmacology

Quan Zhu
Kaixuan Li
Haozhen Li
Feng Han
Zhengyan Tang
Zhao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.743682

5,130 views
10 citations

Original Research

Published on 28 Jan 2022

The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

in Renal Pharmacology

Ming-Hsien Tsai
Mingchih Chen
Yen-Chun Huang
Hung-Hsiang Liou
Yu-Wei Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.804000

2,602 views
3 citations

Original Research

Published on 27 Jan 2022

Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways

in Renal Pharmacology

Qian Ren
Bo Wang
Fan Guo
Rongshuang Huang
Zhouke Tan
Liang Ma
Ping Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.792139

5,474 views
25 citations

Review

Published on 25 Jan 2022

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis

in Renal Pharmacology

Jun Li
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.820071

6,003 views
23 citations

Original Research

Published on 25 Jan 2022

Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones

in Renal Pharmacology

Laura Szalai
András Sziráki
László Sándor Erdélyi
Kinga Bernadett Kovács
Miklós Tóth
András Dávid Tóth
Gábor Turu
Dominique Bonnet
Bernard Mouillac
László Hunyady

Frontiers in Pharmacology

doi 10.3389/fphar.2022.811836

6,562 views
12 citations

Original Research

Published on 24 Jan 2022

Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition

in Renal Pharmacology

Meilian Yu
Lingzhi Li
Qian Ren
Han Feng
Sibei Tao
Lu Cheng
Liang Ma
Shen-Ju Gou
Ping Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.783679

3,924 views
15 citations

Original Research

Published on 24 Jan 2022

Nephrotoxicity of Calcineurin Inhibitors in Kidney Epithelial Cells is Independent of NFAT Signaling

in Renal Pharmacology

Andrea Karolin
Geneviève Escher
Stefan Rudloff
Daniel Sidler

Frontiers in Pharmacology

doi 10.3389/fphar.2021.789080

5,723 views
10 citations

Opinion

Published on 24 Jan 2022

Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease

in Renal Pharmacology

Li-Min Zhao
Ze-Lin Zhan
Jie Ning
Mei Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.751496

7,742 views
12 citations